PhiloGene Inc. Announces Revolutionary Advances in the Treatment of Cancer and Macular Degeneration at BIO National Venture Conference 2008. The preclinical anti-cancer and ophthalmic experiments were performed using VEGFb produced at PPS.

http://www.philogene-inc.com/newsinfo3.html#